Pages that link to "Q34322414"

The following pages link to Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205). (Q34322414):

Displaying 41 items.

• Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene (Q24607219) (← links)
• IMP dehydrogenase: structure, mechanism, and inhibition (Q24642299) (← links)
• Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration? (Q24642828) (← links)
• Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis (Q24642869) (← links)
• IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA (Q24643480) (← links)
• Retinal isoforms of inosine 5'-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins (Q24647325) (← links)
• Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice (Q24682900) (← links)
• Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy (Q26766115) (← links)
• Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms (Q27332315) (← links)
• Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design (Q27617777) (← links)
• Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid (Q27733135) (← links)
• Loukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal Cells (Q28553081) (← links)
• Neural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeleton (Q28834482) (← links)
• Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis (Q33481705) (← links)
• Inosine monophosphate dehydrogenase expression and activity are significantly lower in kidney transplant recipients with diabetes mellitus (Q33942729) (← links)
• Investigating the mechanism of disease in the RP10 form of retinitis pigmentosa (Q33961074) (← links)
• Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation (Q34175259) (← links)
• Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics (Q34442343) (← links)
• IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance. (Q34568904) (← links)
• IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations (Q36535994) (← links)
• On the role of IMPDH1 in retinal degeneration (Q36972991) (← links)
• Pharmacogenetic influences on mycophenolate therapy (Q37710509) (← links)
• Inosine Monophosphate Dehydrogenase as a Target for Antiviral, Anticancer, Antimicrobial and Immunosuppressive Therapeutics (Q37855856) (← links)
• Base-functionalized carbocyclic nucleosides: design, synthesis, and mechanism of antiviral activity (Q39319202) (← links)
• IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine (Q39963834) (← links)
• Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway (Q40412842) (← links)
• Specific inhibition of type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acids (Q40803751) (← links)
• Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions (Q41003479) (← links)
• Conformational changes and stabilization of inosine 5'-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid (Q42634081) (← links)
• Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro (Q42716282) (← links)
• Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death (Q43620595) (← links)
• Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: potent inhibitors of human type II inosine 5'-monophosphate dehydrogenase (Q43773482) (← links)
• A mutational analysis of the active site of human type II inosine 5'-monophosphate dehydrogenase (Q43875214) (← links)
• Proteomics reveals changes in hepatic proteins during chicken embryonic development: an alternative model to study human obesity (Q47223871) (← links)
• Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters (Q48053887) (← links)
• Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. (Q55068013) (← links)
• IMP/GTP balance modulates cytoophidium assembly and IMPDH activity. (Q55382907) (← links)
• Immune Response-Dependent Assembly of IMP Dehydrogenase Filaments (Q59800410) (← links)
• Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story (Q90080170) (← links)
• Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation (Q93058477) (← links)
• Disease Progression in Patients with Autosomal Dominant Retinitis Pigmentosa due to a Mutation in Inosine Monophosphate Dehydrogenase 1 (IMPDH1) (Q98613374) (← links)